Blueberry Therapeutics
A modern drug discovery and development company which puts people first whether patients, employees, investors or partners.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD102m (Public information from Jun 2021)
Company register number 07839535
Macclesfield England (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | <1m | <1m |
| % growth | (95 %) | 1092 % | 532 % | (100 %) | 11930 % | - | 20 % |
| EBITDA | (1.9m) | (2.7m) | (3.9m) | (5.4m) | (4.0m) | (4.1m) | (4.8m) |
| % EBITDA margin | (24749 %) | (2970 %) | (684 %) | (1080896 %) | (6729 %) | (6748 %) | (6634 %) |
| Profit | (1.9m) | (2.5m) | (3.6m) | (5.2m) | (2.5m) | (3.4m) | (4.0m) |
| % profit margin | (24965 %) | (2767 %) | (640 %) | (1044309 %) | (4076 %) | (5576 %) | (5492 %) |
| R&D budget | - | - | <1m | - | - | - | - |
| R&D % of revenue | - | - | 70 % | - | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
£100k | Grant | ||
| N/A | N/A | Seed | |
£3.0m | Early VC | ||
* | £10.0m | Late VC | |
N/A | Grant | ||
£3.6m Valuation: £50.0m 120000.0x EV/LTM Revenues -11.1x EV/LTM EBITDA | Series B | ||
£750k Valuation: £50.0m 120000.0x EV/LTM Revenues -11.1x EV/LTM EBITDA | Late VC | ||
| Total Funding | AUD35.6m | ||
Recent News about Blueberry Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.